Randomized Pragmatic Clinical Trial in a Community-Based Setting Comparing STIOLTO® RESPIMAT® vs. ICS-LABA Plus LAMA in Patients With COPD
Phase of Trial: Phase IV
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Olodaterol/tiotropium bromide (Primary) ; Budesonide/formoterol/glycopyrrolate
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms AIRWISE
- Sponsors Boehringer Ingelheim
- 06 Oct 2017 Last checked against ClinicalTrials.gov record
- 05 Oct 2017 According to a Boehringer Ingelheim Pharmaceuticals media release, first patient has been enrolled.
- 26 Sep 2017 Status changed from not yet recruiting to recruiting.